Drug of choice for generalized anxiety –
## **Core Concept**
Generalized anxiety disorder (GAD) is a condition characterized by excessive worry about everyday things that is difficult to control. The management of GAD often involves pharmacotherapy, with a focus on medications that can effectively reduce anxiety symptoms.
## **Why the Correct Answer is Right**
The correct answer, . (typically referring to selective serotonin reuptake inhibitors or SSRIs, such as sertraline or fluoxetine, but most specifically for generalized anxiety disorder, it might lean towards SNRIs like venlafaxine or duloxetine, or specific anxiolytics), is right because SSRIs and SNRIs are considered first-line treatments for generalized anxiety disorder due to their efficacy and relatively favorable side effect profile. They work by **increasing the levels of serotonin** in the brain, which helps to reduce anxiety. For instance, **sertraline and paroxetine** are specifically approved for the treatment of GAD.
## **Why Each Wrong Option is Incorrect**
- **Option A:** - This option might represent a different class of medications not primarily used for GAD, such as typical antipsychotics or antihistamines, which might have some anxiolytic effects but are not considered first-line due to side effects and the availability of more targeted therapies.
- **Option B:** - This could represent another class of drugs, possibly benzodiazepines, which are effective for short-term relief of anxiety but are generally not recommended for long-term treatment of GAD due to the risk of dependence.
- **Option D:** - This might represent a different type of medication altogether, such as **monoamine oxidase inhibitors (MAOIs)**, which are not typically used as first-line treatment for GAD due to dietary restrictions, side effects, and interactions.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while **SSRIs and SNRIs** are first-line treatments for generalized anxiety disorder, **benzodiazepines** should generally be avoided for long-term management due to the risk of **dependence and withdrawal**. For patients who cannot tolerate or do not respond to SSRIs/SNRIs, **azapirones (buspirone)** can be considered as an alternative.
## **Correct Answer:** .